449 related articles for article (PubMed ID: 33657326)
1. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Biswas A; De S
Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
[TBL] [Abstract][Full Text] [Related]
2. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
Nijman SMB
Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
[TBL] [Abstract][Full Text] [Related]
3. Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence.
Vessoni AT; Filippi-Chiela EC; Lenz G; Batista LFZ
Oncogene; 2020 Mar; 39(10):2055-2068. PubMed ID: 31801972
[TBL] [Abstract][Full Text] [Related]
4. Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!
Wooten DJ; Quaranta V
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):167-175. PubMed ID: 28396217
[TBL] [Abstract][Full Text] [Related]
5. A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
Stanta G; Bonin S
Pathobiology; 2018; 85(1-2):7-17. PubMed ID: 28750401
[TBL] [Abstract][Full Text] [Related]
6. Changing mutational and adaptive landscapes and the genesis of cancer.
Liggett LA; DeGregori J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
[TBL] [Abstract][Full Text] [Related]
7. Intratumor Heterogeneity in Breast Cancer.
Beca F; Polyak K
Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of intratumor heterogeneity: challenges and opportunities.
Ramón Y Cajal S; Sesé M; Capdevila C; Aasen T; De Mattos-Arruda L; Diaz-Cano SJ; Hernández-Losa J; Castellví J
J Mol Med (Berl); 2020 Feb; 98(2):161-177. PubMed ID: 31970428
[TBL] [Abstract][Full Text] [Related]
9. Cancer Plasticity: The Role of mRNA Translation.
Lee LJ; Papadopoli D; Jewer M; Del Rincon S; Topisirovic I; Lawrence MG; Postovit LM
Trends Cancer; 2021 Feb; 7(2):134-145. PubMed ID: 33067172
[TBL] [Abstract][Full Text] [Related]
10. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
11. Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.
Marusyk A; Janiszewska M; Polyak K
Cancer Cell; 2020 Apr; 37(4):471-484. PubMed ID: 32289271
[TBL] [Abstract][Full Text] [Related]
12. Rare Mutations in Cancer Drug Resistance and Implications for Therapy.
Beckman RA; Loeb LA
Clin Pharmacol Ther; 2020 Sep; 108(3):437-439. PubMed ID: 32648584
[No Abstract] [Full Text] [Related]
13. Hypoxia-driven intratumor heterogeneity and immune evasion.
Terry S; Engelsen AST; Buart S; Elsayed WS; Venkatesh GH; Chouaib S
Cancer Lett; 2020 Nov; 492():1-10. PubMed ID: 32712233
[TBL] [Abstract][Full Text] [Related]
14. New insights from the widening homogeneity perspective to target intratumor heterogeneity.
Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q
Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517
[TBL] [Abstract][Full Text] [Related]
15. Intratumor heterogeneity: seeing the wood for the trees.
Yap TA; Gerlinger M; Futreal PA; Pusztai L; Swanton C
Sci Transl Med; 2012 Mar; 4(127):127ps10. PubMed ID: 22461637
[TBL] [Abstract][Full Text] [Related]
16. Intratumor heterogeneity in epigenetic patterns.
Assenov Y; Brocks D; Gerhäuser C
Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
[TBL] [Abstract][Full Text] [Related]
17. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.
Brychtová V; Valík V; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018
[TBL] [Abstract][Full Text] [Related]
18. Intratumor heterogeneity: evolution through space and time.
Swanton C
Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
[TBL] [Abstract][Full Text] [Related]
19. Evolutionary scalpels for dissecting tumor ecosystems.
Rosenbloom DIS; Camara PG; Chu T; Rabadan R
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):69-83. PubMed ID: 27923679
[TBL] [Abstract][Full Text] [Related]
20. Group Behavior and Emergence of Cancer Drug Resistance.
Bhattacharya S; Mohanty A; Achuthan S; Kotnala S; Jolly MK; Kulkarni P; Salgia R
Trends Cancer; 2021 Apr; 7(4):323-334. PubMed ID: 33622644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
